Maselli, F.M.; Giuliani, F.; Laface, C.; Perrone, M.; Melaccio, A.; De Santis, P.; Santoro, A.N.; Guarini, C.; Iaia, M.L.; Fedele, P.
Immunotherapy in Prostate Cancer: State of Art and New Therapeutic Perspectives. Curr. Oncol. 2023, 30, 5769-5794.
https://doi.org/10.3390/curroncol30060432
AMA Style
Maselli FM, Giuliani F, Laface C, Perrone M, Melaccio A, De Santis P, Santoro AN, Guarini C, Iaia ML, Fedele P.
Immunotherapy in Prostate Cancer: State of Art and New Therapeutic Perspectives. Current Oncology. 2023; 30(6):5769-5794.
https://doi.org/10.3390/curroncol30060432
Chicago/Turabian Style
Maselli, Felicia Maria, Francesco Giuliani, Carmelo Laface, Martina Perrone, Assunta Melaccio, Pierluigi De Santis, Anna Natalizia Santoro, Chiara Guarini, Maria Laura Iaia, and Palma Fedele.
2023. "Immunotherapy in Prostate Cancer: State of Art and New Therapeutic Perspectives" Current Oncology 30, no. 6: 5769-5794.
https://doi.org/10.3390/curroncol30060432
APA Style
Maselli, F. M., Giuliani, F., Laface, C., Perrone, M., Melaccio, A., De Santis, P., Santoro, A. N., Guarini, C., Iaia, M. L., & Fedele, P.
(2023). Immunotherapy in Prostate Cancer: State of Art and New Therapeutic Perspectives. Current Oncology, 30(6), 5769-5794.
https://doi.org/10.3390/curroncol30060432